Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - CHANGE IN WORKING CAPITAL
Change in Working Capital AKBA - Akebia Therapeutics, Inc.
-20.7 M
LAST VALUE
56.28%
2 YEAR CAGR
-9.52%
5 YEAR CAGR
-27.93%
10 YEAR CAGR